In children undergoing ESWL, adjunctive α1-blocker therapy enhances the stone-free rate and reduces the stone expulsion time. Children with urolithiasis who receive adjunctive α1-blocker therapy after ...
Doxazosin remains a commonly used antihypertensive medication, although its use has been tainted by recent findings from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial ...
Bio-miR: A prognostic microRNA-based signature for localized clear cell renal cell carcinoma. This is an ASCO Meeting Abstract from the 2022 ASCO Annual Meeting I. This abstract does not include a ...
Reductions in violence are seen in individuals using Beta adrenergic-blocking agents (Beta-blockers) compared with periods that they are not taking the medication, a new study finds. If the findings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results